BROWN ADVISORY INC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
BROWN ADVISORY INC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$113,687,000
+1.2%
752,048
-2.5%
0.22%
+4.7%
Q2 2022$112,368,000
+7.3%
771,172
-12.7%
0.21%
+35.3%
Q1 2022$104,765,000
-10.4%
883,570
+4.1%
0.16%
+7.6%
Q4 2021$116,984,000
-18.5%
848,879
-17.8%
0.14%
-31.6%
Q3 2021$143,523,000
+42.0%
1,033,202
-0.8%
0.21%
+39.5%
Q2 2021$101,097,000
+49.5%
1,041,365
+5.2%
0.15%
+31.0%
Q1 2021$67,644,000
-11.2%
989,688
+11.4%
0.12%
-14.1%
Q4 2020$76,135,000
+36.3%
888,284
+3.4%
0.14%
+17.4%
Q3 2020$55,868,000
-9.9%
859,393
+1.3%
0.12%
-20.1%
Q2 2020$61,999,000
+133.4%
848,019
+8.7%
0.14%
+77.8%
Q1 2020$26,559,000
-31.1%
780,441
+10.3%
0.08%
-17.3%
Q4 2019$38,527,000
-15.3%
707,684
-35.1%
0.10%
-23.4%
Q3 2019$45,475,000
+3.0%
1,089,992
+8.1%
0.13%
+1.6%
Q2 2019$44,144,000
+36.7%
1,008,046
+60.7%
0.13%
+37.0%
Q1 2019$32,285,000
+92.6%
627,282
+38.3%
0.09%
+64.3%
Q4 2018$16,766,000453,4090.06%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders